Dicerna Pharmaceutic (DRNA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | DRNA | AZN | AMGN | GILD | BMY |
| Company | Dicerna Pharmaceutic | Astrazeneca Plc | Amgen Inc | Gilead Sciences Inc | Bristol-Myers Squibb Company |
| Price Information | |||||
| Exchange | NASDAQ | NYSE | NASDAQ | NASDAQ | NYSE |
| Open | 38.21 | 208.99 | 380.02 | 149.72 | 61.11 |
| High | 38.24 | 209.35 | 383.20 | 150.08 | 61.91 |
| Low | 38.21 | 206.49 | 378.82 | 147.05 | 61.01 |
| Latest | 38.22 | 206.61 | 382.87 | 147.64 | 61.60 |
| Change | +0.22 | +1.67 | +3.45 | -2.19 | +0.35 |
| % Change | +0.58% | +0.81% | +0.91% | -1.46% | +0.57% |
| Volume | 5,568,900 | 1,710,900 | 2,454,800 | 8,334,000 | 13,237,900 |
| 20-Day Average Volume | 3,647,665 | 2,822,647 | 3,034,900 | 7,975,775 | 13,381,540 |
| Previous Close | 38.00 | 204.94 | 379.42 | 149.83 | 61.25 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | No | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 38.03 | 196.37 | 364.40 | 148.30 | 58.83 |
| 20-Day Raw Stochastic | 90.72% | 79.02% | 95.22% | 51.14% | 94.26% |
| 20-Day Relative Strength | 80.40 | 63.24 | 65.19 | 58.51 | 66.55 |
| Weighted Alpha | +35.17 | +45.22 | +34.38 | +38.46 | +17.77 |
| Today's Opinion | 88% Buy | 100% Buy | 100% Buy | 88% Buy | 100% Buy |
| Previous Opinion | 72% Buy | 100% Buy | 100% Buy | 100% Buy | 100% Buy |
| Last Month's Opinion | 24% Buy | 80% Buy | 88% Buy | 100% Buy | 80% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | +1.08% since 12/17/21 | -1.37% since 02/17/26 | +2.55% since 02/17/26 | -4.91% since 02/17/26 | +2.07% since 02/17/26 |
| Low | 37.81 on 12/21/21 | 204.05 on 02/20/26 | 370.44 on 02/18/26 | 147.05 on 02/24/26 | 59.23 on 02/19/26 |
| High | 38.24 on 12/27/21 | 212.71 on 02/18/26 | 383.20 on 02/24/26 | 156.01 on 02/18/26 | 61.91 on 02/24/26 |
| 1-Month | |||||
| %Chg | +0.61% since 11/26/21 | +11.14% since 01/23/26 | +11.06% since 01/23/26 | +8.61% since 01/23/26 | +12.72% since 01/23/26 |
| Low | 37.78 on 12/10/21 | 183.63 on 02/03/26 | 338.07 on 01/30/26 | 133.69 on 01/26/26 | 54.21 on 01/29/26 |
| High | 38.26 on 12/03/21 | 212.71 on 02/18/26 | 385.12 on 02/06/26 | 157.29 on 02/11/26 | 62.05 on 02/06/26 |
| 3-Month | |||||
| %Chg | +83.31% since 09/27/21 | +12.88% since 11/24/25 | +14.53% since 11/24/25 | +17.86% since 11/24/25 | +28.98% since 11/24/25 |
| Low | 19.06 on 10/06/21 | 178.08 on 01/21/26 | 312.39 on 12/11/25 | 116.88 on 01/05/26 | 48.10 on 11/25/25 |
| High | 38.26 on 12/03/21 | 212.71 on 02/18/26 | 385.12 on 02/06/26 | 157.29 on 02/11/26 | 62.05 on 02/06/26 |
| 6-Month | |||||
| %Chg | +1.95% since 06/25/21 | +27.58% since 08/22/25 | +30.35% since 08/22/25 | +28.64% since 08/22/25 | +28.55% since 08/22/25 |
| Low | 19.06 on 10/06/21 | 145.79 on 09/25/25 | 269.77 on 09/26/25 | 108.46 on 10/02/25 | 42.52 on 10/29/25 |
| High | 40.14 on 07/20/21 | 212.71 on 02/18/26 | 385.12 on 02/06/26 | 157.29 on 02/11/26 | 62.05 on 02/06/26 |
| Key Statistics | |||||
| Market Capitalization, $K | 2,986,090 | 317,843,072 | 204,533,184 | 185,891,104 | 124,734,032 |
| Shares Outstanding, K | 78,129 | 1,550,908 | 539,068 | 1,240,680 | 2,036,474 |
| Annual Sales | 164,310,000 | 58,739,000,000 | 36,751,000,000 | 29,443,000,000 | 48,194,000,000 |
| Annual Net Income | -112,750,000 | 10,225,000,000 | 7,711,000,000 | 8,510,000,000 | 7,054,000,000 |
| Last Quarter Sales | 62,950,000 | 15,503,000,000 | 9,866,000,000 | 7,925,000,000 | 12,502,000,000 |
| Last Quarter Net Income | -17,070,000 | 2,326,000,000 | 1,333,000,000 | 2,183,000,000 | 1,086,000,000 |
| 60-Month Beta | 0.80 | 0.34 | 0.46 | 0.36 | 0.29 |
| Per-Share Information | |||||
| Most Recent Earnings | N/A on 11/09/21 | 2.12 on 02/10/26 | 5.29 on 02/03/26 | 1.86 on 02/10/26 | 1.26 on 02/05/26 |
| Latest Earnings Date | 02/24/22 | 05/05/26 | 05/07/26 | 04/23/26 | 04/23/26 |
| Most Recent Dividend | N/A | 2.170 on 02/20/26 | 2.520 on 02/13/26 | 0.790 on 12/15/25 | 0.630 on 01/02/26 |
| Next Ex-Dividends Date | N/A | 02/20/26 | 02/13/26 | 03/13/26 | 01/02/26 |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 25.21 | 17.15 | 18.58 | 9.86 |